You just read:

ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardt's Disease

News provided by

Advanced Cell Technology, Inc.

Mar 10, 2011, 08:30 EST